Botswana Combination Prevention Project

NCT01965470 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2022-11-14

No results posted yet for this study

Summary

The BCPP study is designed to test the hypothesis that implementing an enhanced combination prevention package which includes provision of ART to all participants, regardless of CD4 count or HIV disease severity, will impact the HIV/AIDS epidemic by significantly reducing population-level, cumulative HIV incidence in a defined geographic area over a period of 3 years and will be cost-effective.

Conditions

Interventions

OTHER

Combination Prevention

OTHER

Enhanced Care

Sponsors & Collaborators

  • Botswana Harvard AIDS Institute Partnership

    collaborator OTHER
  • Botswana Ministry of Health

    collaborator OTHER_GOV
  • Harvard School of Public Health (HSPH)

    collaborator OTHER
  • Tebelopele Voluntary Counseling and Testing Center

    collaborator UNKNOWN
  • Centers for Disease Control and Prevention

    lead FED

Principal Investigators

  • Janet S Moore, PhD · Centers for Disease Control and Prevention

  • Myron Essex, DVM, PhD · Harvard School of Public Health (HSPH)

  • Refeletswe Lebelonyane, MD · Botswana Ministry of Health

  • Shenaaz El Halabi, MPH · Botswana Ministry of Health

  • Joseph Makhema, MBChB, FRCP · Botswana Harvard AIDS Institute Partnership

  • Shahin Lockman, MD, MS · Harvard School of Public Health (HSPH)

  • Eric Tchetgen Tchetgen, PhD · Harvard School of Public Health (HSPH)

  • Molly Pretorius Holme, MS · Harvard School of Public Health (HSPH)

  • Pam Bachanas, PhD · Centers for Disease Control and Prevention

  • Tafireyi Marukutira, MD · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-30
Primary Completion
2018-07-26
Completion
2018-07-26

Countries

  • Botswana

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01965470 on ClinicalTrials.gov